Translating stem cell research to cardiac disease therapies: Pitfalls and prospects for improvement three sections with opinions separately and independently expressed by

Michael R. Rosen, Robert J Myerburg, Darrel P. Francis, Graham D. Cole, Eduardo Marbán

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

Over the past 2 decades, there have been numerous stem cell studies focused on cardiac diseases, ranging from proof-of-concept to phase 2 trials. This series of papers focuses on the legacy of these studies and the outlook for future treatment of cardiac diseases with stem cell therapies. The first section by Drs. Rosen and Myerburg is an independent review that analyzes the basic science and translational strategies supporting the rapid advance of stem cell technology to the clinic, the philosophies behind them, trial designs, and means for going forward that may impact favorably on progress. The second and third sections were collected as responses to the initial section of this review. The commentary by Drs. Francis and Cole discusses the review by Drs. Rosen and Myerburg and details how trial outcomes can be affected by noise, poor trial design (particularly the absence of blinding), and normal human tendencies toward optimism and denial. The final, independent paper by Dr. Marbán takes a different perspective concerning the potential for positive impact of stem cell research applied to heart disease and future prospects for its clinical application. (Compiled by the JACC editors).

Original languageEnglish
Pages (from-to)922-937
Number of pages16
JournalJournal of the American College of Cardiology
Volume64
Issue number9
DOIs
StatePublished - Sep 2 2014

Fingerprint

Stem Cell Research
Heart Diseases
Stem Cells
Cell- and Tissue-Based Therapy
Noise
Therapeutics
Technology

Keywords

  • cell-based therapy
  • heart diseases
  • research design
  • stem cell research
  • stem cell transplantation
  • tissue-based therapy

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Translating stem cell research to cardiac disease therapies : Pitfalls and prospects for improvement three sections with opinions separately and independently expressed by. / Rosen, Michael R.; Myerburg, Robert J; Francis, Darrel P.; Cole, Graham D.; Marbán, Eduardo.

In: Journal of the American College of Cardiology, Vol. 64, No. 9, 02.09.2014, p. 922-937.

Research output: Contribution to journalArticle

@article{b6e174695e9b4a95b07e5c10fcf35b59,
title = "Translating stem cell research to cardiac disease therapies: Pitfalls and prospects for improvement three sections with opinions separately and independently expressed by",
abstract = "Over the past 2 decades, there have been numerous stem cell studies focused on cardiac diseases, ranging from proof-of-concept to phase 2 trials. This series of papers focuses on the legacy of these studies and the outlook for future treatment of cardiac diseases with stem cell therapies. The first section by Drs. Rosen and Myerburg is an independent review that analyzes the basic science and translational strategies supporting the rapid advance of stem cell technology to the clinic, the philosophies behind them, trial designs, and means for going forward that may impact favorably on progress. The second and third sections were collected as responses to the initial section of this review. The commentary by Drs. Francis and Cole discusses the review by Drs. Rosen and Myerburg and details how trial outcomes can be affected by noise, poor trial design (particularly the absence of blinding), and normal human tendencies toward optimism and denial. The final, independent paper by Dr. Marb{\'a}n takes a different perspective concerning the potential for positive impact of stem cell research applied to heart disease and future prospects for its clinical application. (Compiled by the JACC editors).",
keywords = "cell-based therapy, heart diseases, research design, stem cell research, stem cell transplantation, tissue-based therapy",
author = "Rosen, {Michael R.} and Myerburg, {Robert J} and Francis, {Darrel P.} and Cole, {Graham D.} and Eduardo Marb{\'a}n",
year = "2014",
month = "9",
day = "2",
doi = "10.1016/j.jacc.2014.06.1175",
language = "English",
volume = "64",
pages = "922--937",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "9",

}

TY - JOUR

T1 - Translating stem cell research to cardiac disease therapies

T2 - Pitfalls and prospects for improvement three sections with opinions separately and independently expressed by

AU - Rosen, Michael R.

AU - Myerburg, Robert J

AU - Francis, Darrel P.

AU - Cole, Graham D.

AU - Marbán, Eduardo

PY - 2014/9/2

Y1 - 2014/9/2

N2 - Over the past 2 decades, there have been numerous stem cell studies focused on cardiac diseases, ranging from proof-of-concept to phase 2 trials. This series of papers focuses on the legacy of these studies and the outlook for future treatment of cardiac diseases with stem cell therapies. The first section by Drs. Rosen and Myerburg is an independent review that analyzes the basic science and translational strategies supporting the rapid advance of stem cell technology to the clinic, the philosophies behind them, trial designs, and means for going forward that may impact favorably on progress. The second and third sections were collected as responses to the initial section of this review. The commentary by Drs. Francis and Cole discusses the review by Drs. Rosen and Myerburg and details how trial outcomes can be affected by noise, poor trial design (particularly the absence of blinding), and normal human tendencies toward optimism and denial. The final, independent paper by Dr. Marbán takes a different perspective concerning the potential for positive impact of stem cell research applied to heart disease and future prospects for its clinical application. (Compiled by the JACC editors).

AB - Over the past 2 decades, there have been numerous stem cell studies focused on cardiac diseases, ranging from proof-of-concept to phase 2 trials. This series of papers focuses on the legacy of these studies and the outlook for future treatment of cardiac diseases with stem cell therapies. The first section by Drs. Rosen and Myerburg is an independent review that analyzes the basic science and translational strategies supporting the rapid advance of stem cell technology to the clinic, the philosophies behind them, trial designs, and means for going forward that may impact favorably on progress. The second and third sections were collected as responses to the initial section of this review. The commentary by Drs. Francis and Cole discusses the review by Drs. Rosen and Myerburg and details how trial outcomes can be affected by noise, poor trial design (particularly the absence of blinding), and normal human tendencies toward optimism and denial. The final, independent paper by Dr. Marbán takes a different perspective concerning the potential for positive impact of stem cell research applied to heart disease and future prospects for its clinical application. (Compiled by the JACC editors).

KW - cell-based therapy

KW - heart diseases

KW - research design

KW - stem cell research

KW - stem cell transplantation

KW - tissue-based therapy

UR - http://www.scopus.com/inward/record.url?scp=84907305378&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907305378&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2014.06.1175

DO - 10.1016/j.jacc.2014.06.1175

M3 - Article

C2 - 25169179

AN - SCOPUS:84907305378

VL - 64

SP - 922

EP - 937

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 9

ER -